Drug Design Development and Therapy · 2014 · 41 citations · 40 references
Confidence intervals as well as intersubject and intrasubject variability were determined for novel clinical renal biomarkers/assays, which should be considered for evaluation in the next steps of the qualification process.
40
Limitations of creatinine as a filtration marker in glomerulopathic patients
Ovadia Shemesh, Helen Golbetz, Joseph P. Kriss et al. · Kidney International · 1985 · 1.2K citations · Full text
Richard C. Cabot, Robert E. Scully, Eugene J. Mark et al. · New England Journal of Medicine · 1990 · 899 citations
Case Records, New England Journal, Massachusetts General Hospital +4
National Surveillance of Emergency Department Visits for Outpatient Adverse Drug Events
Daniel S. Budnitz, Daniel A. Pollock, Kelly N. Weidenbach et al. · JAMA · 2006 · 883 citations